John Edward A. Blair to Hospitalization
This is a "connection" page, showing publications John Edward A. Blair has written about Hospitalization.
Connection Strength
0.961
-
Inhospital and Post-discharge Changes in Renal Function After Transcatheter Aortic Valve Replacement. Am J Cardiol. 2016 Feb 15; 117(4):633-639.
Score: 0.364
-
Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J. 2011 Oct; 32(20):2563-72.
Score: 0.269
-
Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial. Eur Heart J. 2009 Jul; 30(13):1666-73.
Score: 0.230
-
Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am Coll Cardiol. 2008 Nov 11; 52(20):1640-8.
Score: 0.056
-
The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction. Am Heart J. 2009 Sep; 158(3):437-43.
Score: 0.015
-
Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial. Am Heart J. 2009 Jun; 157(6):1035-41.
Score: 0.014
-
Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure. J Am Coll Cardiol. 2008 Jun 10; 51(23):2276-85.
Score: 0.013